(CTN News) – According to a study, babies infected with a winter virus could save over 80% of hospital admissions by receiving just one dose of...
(CTN News) – During the winter months, people are more likely to suffer from lung diseases such as this one. Most RSV cases occur in older...
(CTN NEWS) – As we gear up for the fall season, the Centers for Disease Control and Prevention (CDC) has made a significant recommendation that could...
(CTN NEWS) – New and improved COVID-19 vaccines are on the horizon, perfectly timed to coincide with the administration of flu shots. Furthermore, this autumn marks...
(CTN News) – In a significant breakthrough, the US Food and Drug Administration (FDA) has approved the first-ever vaccine designed to shield newborns from Respiratory Syncytial...
(CTN News) – U.S. officials have approved the first long-acting drug designed to safeguard babies and toddlers from respiratory syncytial virus (RSV), a common respiratory infection...
(CTN News) – In a news release issued on Monday, the FDA Food and Drug Administration approved AstraZeneca and Sanofi’s vaccine that protects infants and toddlers...
(CTN News) – The Centers for Disease Control and Prevention (CDC) advisory committee recently recommended using two newly approved respiratory syncytial virus (RSV) vaccines for adults...
(CTN News) – GlaxoSmithKline (GSK) has announced positive results from a phase three clinical trial, indicating the continued effectiveness of its respiratory syncytial virus (RSV) vaccine...
(CTN News) – The Centers for Disease Control and Prevention (CDC) is expected to vote on Wednesday on whether to recommend the use of recently approved...
(CTN News) – Among the top causes of newborn hospitalization is an (RSV) respiratory syncytial virus, and a panel of independent advisors to the FDA unanimously...
(CTN News) – Wednesday, the FDA approved the RSV vaccine from drugmaker GSK to protect seniors against the virus that causes thousands of hospitalizations and deaths...
(CTN News) – At a meeting Tuesday, Pfizer’s vaccine candidate for respiratory syncytial virus (RSV), Abrysvo, won over FDA expert advisors despite safety signals and study...
(CTN News) – On Tuesday, Moderna claimed that their anti-respiratory syncytial virus RSV vaccine successfully avoided illness in older persons. According to the Boston biotech business,...
(CTN News) – Some of the nation’s top health experts are urging people to wear face masks again, but this time, it’s not simply because of...
(CTN News) – It has been approved for use in Europe by Sanofi and AstraZeneca Plc’s Beyfortus. This is to protect infants against respiratory syncytial virus,...
(CTN News) – GlaxoSmithKline (GLAX.NS) sued Pfizer (PFE.N) and BioNTech (22UAy.DE) in Delaware federal court on Thursday, accusing them of infringing on GSK patents linked to...
(CTN News) – A patent lawsuit filed by Moderna (MRNA.O) alleging that Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab copied its COVID-19...
(CTN News) – On Thursday, the Korean Disease Control and Prevention Agency announced that, as variants of the COVID-19 virus are still posing a risk to...
(CTN News) – Earlier this week, Moderna announced that Blackstone’s life sciences arm would contribute $750 million to its flu vaccine development, supporting the company’s efforts...